These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Warner heart oration--1979. Vasodilators in heart failure. Ghosh JC Indian Heart J; 1979; 31(4):191-202. PubMed ID: 489034 [No Abstract] [Full Text] [Related]
24. Is calcium sensitization the best strategy to improve myocardial contractility in acute heart failure? Erhardt LR Ital Heart J; 2003 May; 4 Suppl 2():27S-33S. PubMed ID: 14635367 [TBL] [Abstract][Full Text] [Related]
25. [Heart insufficiency: current aspects of physiopathology and therapy]. Bolte HD Med Klin; 1981 Nov; 76(24):664-71. PubMed ID: 7311926 [No Abstract] [Full Text] [Related]
26. [Recent concepts and methods of treatment of cardiac insufficiency]. Chiche P; Derrida JP; Baligadoo S Coeur Med Interne; 1979; 18(2):229-38. PubMed ID: 385216 [No Abstract] [Full Text] [Related]
27. [Peripheral adaptation in chronic heart failure: therapeutic implications]. Drexler H Herz; 1991 Sep; 16 Spec No 1():334-9. PubMed ID: 1820301 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacology of vasodilator drugs; recent developments]. van Zwieten PA; van Meel JC; de Jonge A; Kalkman HO; Timmermans PB Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():78-86. PubMed ID: 7187165 [No Abstract] [Full Text] [Related]
30. Enalapril in children with congestive heart failure. Eronen M; Pesonen E; Wallgren EI; Tikkanen I; Fyhrquist F; Andersson S Acta Paediatr Scand; 1991 May; 80(5):555-8. PubMed ID: 1872182 [No Abstract] [Full Text] [Related]
31. Pathophysiologic strategies in the management of congestive heart failure. Brozena S; Jessup M Annu Rev Med; 1990; 41():65-74. PubMed ID: 2184749 [TBL] [Abstract][Full Text] [Related]
32. [Comparative evaluation of the effect of digoxin, strophanthin, isolanid and corglycon on the indices of central hemodynamics, vascular tonus, circulating blood volume and myocardial contractility in acute heart failure]. Tsyganiĭ AA; Kovalev NL; Kozlovskiĭ VI; Malinovskiĭ OP; Pen'kov GI Anesteziol Reanimatol; 1981; (3):44-8. PubMed ID: 7294441 [No Abstract] [Full Text] [Related]
33. [Systolic intervals in dilated heart insufficiency. Influence of vasodilator treatment]. González-Juanatey JR; Amaro Cendón A; Vega Fernández M; Gil de la Peña M Med Clin (Barc); 1988 Jan; 90(3):93-6. PubMed ID: 3280894 [No Abstract] [Full Text] [Related]
34. Recent advances in the management of chronic heart failure. Chatterjee K Prim Care; 1985 Mar; 12(1):117-42. PubMed ID: 3846305 [TBL] [Abstract][Full Text] [Related]
35. Vasodilator and inotropic therapy for heart failure. DiPalma JR Am Fam Physician; 1985 Jun; 31(6):177-80. PubMed ID: 4013962 [No Abstract] [Full Text] [Related]
36. [Clinical experiences and value of vasodilation in myocardial insufficiency]. Just H Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():87-97. PubMed ID: 7187166 [No Abstract] [Full Text] [Related]
37. [Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency]. Gronda E; Mafrici A; Ferrari D; Cataldo G; Salvadè P; Pirelli S; Mauri F; Faletra F; Carù B G Ital Cardiol; 1981; 11(6):803-11. PubMed ID: 7319186 [No Abstract] [Full Text] [Related]
38. Concepts of peripheral circulatory control: implications for vasodilator therapy in heart failure. Rubin SA; Swan HJ Cardiovasc Clin; 1984; 14(3):19-29. PubMed ID: 6144389 [No Abstract] [Full Text] [Related]
39. Treatment of refractory heart failure with infusion of nitroprusside. Guiha NH; Cohn JN; Mikulic E; Franciosa JA; Limas CJ N Engl J Med; 1974 Sep; 291(12):587-92. PubMed ID: 4855255 [No Abstract] [Full Text] [Related]